Dube Michael P Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$54,959.08

Insider Activity of Dube Michael P

According to the SEC Form 4 filings, Dube Michael P, being in a position of

  1. VP, Chief Accounting Officer at Intellia Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 7494 shares for $95,014,
    over all time since 2024-10-02, has bought 0 shares, and sold 15252 shares for $207,396.

Biography of Dube Michael P

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$95,0143100

Comparison of Insiders on Amount of Buys and Sells

2026-10-02SaleIntellia Therapeutics, Inc.
NTLA
VP, Chief Accounting Officer
1,864
0.0014%
$12.43$23,170-3.34%
2026-07-01SaleIntellia Therapeutics, Inc.
NTLA
VP, Chief Accounting Officer
2,641
0.0023%
$16.78$44,316-30.05%
2026-01-05SaleIntellia Therapeutics, Inc.
NTLA
VP, Chief Accounting Officer
2,989
0.0028%
$9.21$27,529+36.93%
2025-10-01SaleIntellia Therapeutics, Inc.
NTLA
VP, Chief Accounting Officer
1,871
0.0018%
$17.38$32,518-31.72%
2025-07-02SaleIntellia Therapeutics, Inc.
NTLA
VP, Chief Accounting Officer
2,503
0.0022%
$9.95$24,905+19.38%
2025-01-03SaleIntellia Therapeutics, Inc.
NTLA
VP, Chief Accounting Officer
1,372
0.0013%
$12.18$16,711-19.95%
2024-10-02SaleIntellia Therapeutics, Inc.
NTLA
VP, Chief Accounting Officer
2,012
0.0018%
$19.01$38,248-40.67%
Total: 7
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.